Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB - New York Stock Exchange, Inc. - US7437131094 - Common Stock - Currency: USD

35.17  +0.08 (+0.23%)

After market: 35.17 0 (0%)

Fundamental Rating

5

PRLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. No worries on liquidiy or solvency for PRLB as it has an excellent financial health rating, but there are worries on the profitability. PRLB is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year PRLB was profitable.
In the past year PRLB had a positive cash flow from operations.
PRLB had positive earnings in 4 of the past 5 years.
PRLB had a positive operating cash flow in each of the past 5 years.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.23%, PRLB is in line with its industry, outperforming 40.63% of the companies in the same industry.
PRLB has a worse Return On Equity (2.48%) than 62.50% of its industry peers.
PRLB has a Return On Invested Capital of 2.38%. This is in the lower half of the industry: PRLB underperforms 69.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PRLB is significantly below the industry average of 10.69%.
Industry RankSector Rank
ROA 2.23%
ROE 2.48%
ROIC 2.38%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

PRLB has a Profit Margin (3.31%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of PRLB has declined.
With a Operating Margin value of 5.09%, PRLB is not doing good in the industry: 64.06% of the companies in the same industry are doing better.
PRLB's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 44.56%, PRLB belongs to the best of the industry, outperforming 83.59% of the companies in the same industry.
In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 5.09%
PM (TTM) 3.31%
GM 44.56%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

PRLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PRLB has been reduced compared to 1 year ago.
Compared to 5 years ago, PRLB has less shares outstanding
The debt/assets ratio for PRLB has been reduced compared to a year ago.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.30 indicates that PRLB is not in any danger for bankruptcy at the moment.
The Altman-Z score of PRLB (8.30) is better than 92.19% of its industry peers.
The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PRLB (0.01) is better than 92.97% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PRLB is not too dependend on debt financing.
PRLB has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. PRLB outperforms 88.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 8.3
ROIC/WACC0.24
WACC9.99%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

PRLB has a Current Ratio of 3.66. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB has a better Current ratio (3.66) than 84.38% of its industry peers.
A Quick Ratio of 3.43 indicates that PRLB has no problem at all paying its short term obligations.
The Quick ratio of PRLB (3.43) is better than 90.63% of its industry peers.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.43
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.87% over the past year.
Measured over the past years, PRLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.19% on average per year.
PRLB shows a decrease in Revenue. In the last year, the revenue decreased by -0.61%.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)1.87%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.39%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-2.64%

3.2 Future

The Earnings Per Share is expected to decrease by -0.41% on average over the next years.
PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.30% yearly.
EPS Next Y-13.27%
EPS Next 2Y-0.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.8%
Revenue Next 2Y3.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.58 indicates a rather expensive valuation of PRLB.
PRLB's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of PRLB to the average of the S&P500 Index (28.79), we can say PRLB is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 24.88, the valuation of PRLB can be described as rather expensive.
PRLB's Price/Forward Earnings ratio is in line with the industry average.
PRLB is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.58
Fwd PE 24.88
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PRLB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PRLB is cheaper than 60.94% of the companies in the same industry.
84.38% of the companies in the same industry are more expensive than PRLB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.18
EV/EBITDA 11.71
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.41%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (4/25/2025, 5:38:32 PM)

After market: 35.17 0 (0%)

35.17

+0.08 (+0.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-07 2025-02-07/bmo
Earnings (Next)05-02 2025-05-02/bmo
Inst Owners91.01%
Inst Owner Change-0.22%
Ins Owners0.91%
Ins Owner Change1.77%
Market Cap835.99M
Analysts76.36
Price Target45.22 (28.58%)
Short Float %3%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.89%
Min EPS beat(2)16.42%
Max EPS beat(2)43.37%
EPS beat(4)4
Avg EPS beat(4)23.24%
Min EPS beat(4)7.67%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)30.53%
EPS beat(12)11
Avg EPS beat(12)25.76%
EPS beat(16)12
Avg EPS beat(16)20.02%
Revenue beat(2)1
Avg Revenue beat(2)0.42%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)1.46%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.46%
Revenue beat(8)4
Avg Revenue beat(8)0.63%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.04%
PT rev (1m)0%
PT rev (3m)9.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.58%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-7.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.02%
Valuation
Industry RankSector Rank
PE 21.58
Fwd PE 24.88
P/S 1.67
P/FCF 12.18
P/OCF 10.74
P/B 1.25
P/tB 2.23
EV/EBITDA 11.71
EPS(TTM)1.63
EY4.63%
EPS(NY)1.41
Fwd EY4.02%
FCF(TTM)2.89
FCFY8.21%
OCF(TTM)3.27
OCFY9.31%
SpS21.07
BVpS28.19
TBVpS15.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 2.48%
ROCE 3.69%
ROIC 2.38%
ROICexc 2.8%
ROICexgc 5.63%
OM 5.09%
PM (TTM) 3.31%
GM 44.56%
FCFM 13.71%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 25.61%
Cap/Sales 1.83%
Interest Coverage 187.47
Cash Conversion 126.96%
Profit Quality 413.79%
Current Ratio 3.66
Quick Ratio 3.43
Altman-Z 8.3
F-Score7
WACC9.99%
ROIC/WACC0.24
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.87%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.39%
EPS Next Y-13.27%
EPS Next 2Y-0.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-2.64%
Revenue Next Year1.8%
Revenue Next 2Y3.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.98%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year62.45%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.04%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y6.22%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%